Skip to content
Catalyst

PapersPMID:41282517

Effect of Maternal Moringa oleifera Leaf Supplementation on Maternal and Infant Nutritional Status and Human Milk Output: A Pilot Single-Blinded Cluster-Randomized Trial.

Current developments in nutrition2025The record ↗

  1. Finding, moderate evidenceraisesSerum insulin-like growth factor 1 (IGF-1)

What moved

1 findingHow to read these marks →
  • “Infants of mothers receiving moringa had higher serum IGF-1 concentrations at 3 than did those of mothers in the control group (25.2 ng/mL; 95% CI: 21.0, 29.5 ng/mL, and 17.8 ng/mL; 95% CI: 13.6, 22.0 ng/mL, respectively; P = 0.017), with no difference at baseline (Table 3).”
    Study
    RCT
    Duration
    3 months
    Dose studied
    maternal 20 g/d moringa leaf powder, 10 g in 1 cup of corn flour porridge twice daily, 3 months (estimated consumption 12-15 g/d)
    Population
    breastfed term infants in Kisumu County, Kenya, whose mothers consumed moringa; exposure was maternal, measured in the infant; both arms' mothers ate corn flour porridge

Study record

Design
randomised controlled trial
Species
human
Population
Exclusively breastfeeding mothers (>=18 y) and their term infants (born within 30 d of enrollment), Kisumu County, Kenya; pilot single-blinded cluster-randomized trial with 2 clusters (subcounty hospitals), so treatment is confounded with location. Exposure: dried Moringa oleifera leaf powder 20 g/d in corn porridge vs corn porridge alone for 3 mo.
Participants
50
Comparator
an active treatment / no treatment / placebo
Duration
91 days
Endpoints measured
135